Combined CBT and DBT Skills Group for High-Risk Psychosis
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a new therapy group that combines cognitive behavioral therapy (CBT) and dialectical behavioral therapy (DBT) skills. It targets adolescents and young adults at risk of developing psychosis, a mental health condition affecting perception of reality. Participants will join a weekly skills group to evaluate the effectiveness of this combined approach. Ideal candidates are aged 13-18, already receiving treatment with the HOPE team at the University of Pittsburgh, and showing signs of being at risk for psychosis. As an unphased trial, this study provides a unique opportunity to contribute to innovative mental health research and potentially benefit from a novel therapeutic approach.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It might be best to discuss this with the trial coordinators or your healthcare provider.
What prior data suggests that this skills group is safe for adolescents and young adults at high risk for psychosis?
Research has shown that combining cognitive behavioral therapy (CBT) and dialectical behavioral therapy (DBT) in a skills group is generally safe. These therapies are well-known and often used to help people manage stress and emotions. One study examined a DBT skills group for individuals with psychosis and found it was well-received. Another study on CBT for young people at risk of psychosis also found it to be safe and effective.
These studies reported no major side effects, suggesting that the combined therapy in the skills group is likely safe for participants. However, since this is a new approach, the study aims to test its practicality and effectiveness for teens at high risk of psychosis.12345Why are researchers excited about this trial?
Researchers are excited about the Skills Group for high-risk psychosis because it combines Cognitive Behavioral Therapy (CBT) and Dialectical Behavior Therapy (DBT) skills in a group setting, offering a unique approach not typically seen in conventional treatments. While standard treatments for psychosis often focus on medication and individual therapy, this group setting fosters peer support and skill-building in real-time, which can enhance learning and retention. This innovative approach aims to improve emotional regulation and coping strategies, potentially reducing symptoms and improving quality of life for participants.
What evidence suggests that this skills group is effective for high-risk psychosis?
Research shows that both cognitive behavioral therapy (CBT) and dialectical behavioral therapy (DBT) can help with psychosis. Studies have found that CBT greatly reduces symptoms like hallucinations and delusions. Another study found that DBT skills training improved stress and emotional management in people with psychosis. In this trial, participants will engage in a combined CBT and DBT Skills Group, aiming to teach skills that help those at high risk for psychosis manage stress and emotions more effectively. These therapies are based on proven methods that have shown positive results in managing psychosis symptoms.13678
Who Is on the Research Team?
Leslie Horton, PhD
Principal Investigator
University of Pittsburgh
Are You a Good Fit for This Trial?
This trial is for adolescents and young adults aged 13-18 who are at clinical high-risk (CHR) for psychosis. Participants must be receiving services from the HOPE team at the University of Pittsburgh and meet specific criteria indicating a risk for developing a psychotic disorder, such as having certain symptoms or family history.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants engage in a weekly skills group integrating CBT and DBT for 15 weeks, focusing on stress management, self-disturbance improvement, and social skills enhancement.
Midpoint Assessment
Feasibility and outcome measures are collected to assess progress and group satisfaction.
Follow-up
Participants are monitored for safety and effectiveness after treatment, with assessments of symptoms and functioning.
What Are the Treatments Tested in This Trial?
Interventions
- Skills Group
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Pittsburgh
Lead Sponsor
Substance Abuse and Mental Health Services Administration (SAMHSA)
Collaborator